Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14515015 | 0.87 | HSD17B1 (0.32) | HSD17B1 | |
| SCHEMBL14462522 | 0.87 | HSD17B1 (0.32) | HSD17B1 | |
| SCHEMBL14421889 | 0.86 | HSD17B1 (0.32) | HSD17B1 | |
| SCHEMBL7641127 | 0.80 | KMT2A (0.34) | — | |
| SCHEMBL3711207 | 0.80 | HSD17B1 (0.36) | HSD17B1 | |
| SCHEMBL14174367 | 0.79 | HSD17B1 (0.33) | HSD17B1 | |
| SCHEMBL10007250 | 0.78 | — | — | |
| SCHEMBL10007577 | 0.70 | TSHR (0.30) | — | |
| SCHEMBL9416064 | 0.68 | BRD4 (0.36) | — | |
| SCHEMBL7642136 | 0.67 | MGAM (0.33) | HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7390926-B2 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | ZACH SYSTEM (IT) | 2008-06-24 | — | — | US | disclosed |
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | PPG-SIPSY (FR) | 2007-09-27 | — | — | US | disclosed |
| US-7214832-B2 | Processes for the preparation of bicyclic aminoalcohols | SHIONOGI & CO., LTD. (JP) | 2007-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225516-A1 | Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 | NOP2, NOP10, NOP56 | HSD17B1 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.